Virtu Financial LLC Purchases Shares of 3,127 Cardinal Health, Inc. $CAH

Virtu Financial LLC acquired a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 3,127 shares of the company’s stock, valued at approximately $642,000.

Other hedge funds have also modified their holdings of the company. Nordea Investment Management AB boosted its position in shares of Cardinal Health by 328.3% in the 4th quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock valued at $133,741,000 after purchasing an additional 494,731 shares during the period. Victory Capital Management Inc. raised its holdings in Cardinal Health by 44.9% during the 3rd quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock worth $352,165,000 after buying an additional 707,495 shares during the period. Procyon Advisors LLC lifted its stake in Cardinal Health by 78.7% during the fourth quarter. Procyon Advisors LLC now owns 17,025 shares of the company’s stock valued at $3,499,000 after buying an additional 7,499 shares in the last quarter. Sierra Summit Advisors LLC purchased a new stake in Cardinal Health during the third quarter valued at about $9,897,000. Finally, Banco Santander S.A. boosted its holdings in shares of Cardinal Health by 12.7% in the third quarter. Banco Santander S.A. now owns 117,354 shares of the company’s stock worth $18,420,000 after buying an additional 13,228 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Price Performance

NYSE CAH opened at $223.11 on Tuesday. The firm has a market capitalization of $52.25 billion, a price-to-earnings ratio of 34.11, a price-to-earnings-growth ratio of 1.21 and a beta of 0.52. The company has a 50 day simple moving average of $204.48 and a 200-day simple moving average of $209.41. Cardinal Health, Inc. has a 52-week low of $137.75 and a 52-week high of $233.60.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm’s revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the firm posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is presently 31.19%.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on CAH shares. Zacks Research downgraded shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 12th. Robert W. Baird set a $248.00 price target on shares of Cardinal Health in a research report on Friday, May 1st. Evercore decreased their price objective on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research note on Wednesday, April 8th. Citigroup lowered their price objective on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Finally, Wells Fargo & Company cut their target price on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $246.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.